142 related articles for article (PubMed ID: 26087611)
1. [Therapeutic activity of gemcitabine in intracranial tumors].
Stukov AN; Filatova LV; Latipova DKh; Bespalov VG; Belyaeva OA; Kireeva GS; Vasilieva IN; Alexandrov VA; Maidin MA; Semenov AL; Vershinina SF; Markochev AB; Abduloeva NKh; Chubenko VA; Semiglazova TY
Vopr Onkol; 2015; 61(2):274-9. PubMed ID: 26087611
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Gemcitabine on Intracranial Erlich Tumor and its Determinants.
Stukov AN; Bespalov VG; Alexandrov VA; Semenov AL; Kireeva GS; Semiglazova TY; Filatova LV; Baranenko DA
Drug Res (Stuttg); 2020 Feb; 70(2-03):86-90. PubMed ID: 31556073
[TBL] [Abstract][Full Text] [Related]
3. [Combined effect of gemcitabine and lomustine in mice with intracranial transplanted lymphosarcoma LIO-1].
Stukov AN; Filatova LV; Gershanovich ML; Semiglazova TIu; Tarasenkova AA; Latinova DKh; Vershinina SF; Zargarova NI
Vopr Onkol; 2012; 58(3):394-7. PubMed ID: 22888657
[TBL] [Abstract][Full Text] [Related]
4. [Synergism of antitumor activity of gemcitabine and dioxadet in mice with ascitic Ehrlich's tumor].
Latipova DKh; Gershanovich ML; Stukov AN; Semiglazova TIu; Filatova LV; Tarasenkova AA; Vershinina SF; Kon'kov SA; Krylova IM; Bespalov VG; Panchenko AV; Murazov IaG
Vopr Onkol; 2011; 57(6):767-70. PubMed ID: 22416395
[TBL] [Abstract][Full Text] [Related]
5. Gemcitabine and the blood brain barrier.
Davis JR; Fernandes C; Zalcberg JR
Aust N Z J Med; 1999 Dec; 29(6):831-2. PubMed ID: 10677133
[No Abstract] [Full Text] [Related]
6. An in vitro study of the inhibitory activity of gemcitabine and platinum agents in human endometrial carcinoma cell lines.
Smith JA; Brown J; Martin MC; Ramondetta LM; Wolf JK
Gynecol Oncol; 2004 Jan; 92(1):314-9. PubMed ID: 14751176
[TBL] [Abstract][Full Text] [Related]
7. Gemcitabine and platinum combinations in pancreatic cancer.
Philip PA
Cancer; 2002 Aug; 95(4 Suppl):908-11. PubMed ID: 12209670
[TBL] [Abstract][Full Text] [Related]
8. Antiangiogenic therapy for human pancreatic carcinoma xenografts in nude mice.
Jia L; Zhang MH; Yuan SZ; Huang WG
World J Gastroenterol; 2005 Jan; 11(3):447-50. PubMed ID: 15637766
[TBL] [Abstract][Full Text] [Related]
9. Gemcitabine and small cell lung cancer.
Scarpati MD; Vicidomini G; Santini M
Lung Cancer; 2001 Nov; 34(2):313-4. PubMed ID: 11679191
[No Abstract] [Full Text] [Related]
10. Interaction between cisplatin and gemcitabine in vitro and in vivo.
Peters GJ; Bergman AM; Ruiz van Haperen VW; Veerman G; Kuiper CM; Braakhuis BJ
Semin Oncol; 1995 Aug; 22(4 Suppl 11):72-9. PubMed ID: 7481849
[TBL] [Abstract][Full Text] [Related]
11. Gemcitabine in the treatment of ovarian cancer.
Hansen SW; Tuxen MK; Sessa C
Ann Oncol; 1999; 10 Suppl 1():51-3. PubMed ID: 10219453
[TBL] [Abstract][Full Text] [Related]
12. A randomized study comparing two different schedules of administration of cisplatin in combination with gemcitabine in advanced nonsmall cell lung carcinoma.
Ricci S; Antonuzzo A; Galli L; Tibaldi C; Bertuccelli M; Lopes Pegna A; Petruzzelli S; Bonifazi V; Orlandini C; Franco Conte P
Cancer; 2000 Oct; 89(8):1714-9. PubMed ID: 11042565
[TBL] [Abstract][Full Text] [Related]
13. Gemcitabine and cisplatin in a multimodality treatment for locally advanced non-small cell lung cancer.
Yang CH; Tsai CM; Wang LS; Lee YC; Chang CJ; Lui LT; Yen SH; Hsu C; Cheng AL; Liu MY; Chiang SC; Chen YM; Luh KT; Huang MH; Yang PC; Perng RP
Br J Cancer; 2002 Jan; 86(2):190-5. PubMed ID: 11870504
[TBL] [Abstract][Full Text] [Related]
14. Antineoplastic effect of gemcitabine in an animal model of superficial bladder cancer.
Nativ O; Dalal E; Laufer M; Sabo E; Aronson M
Urology; 2004 Oct; 64(4):845-8. PubMed ID: 15491745
[TBL] [Abstract][Full Text] [Related]
15. [Antitumor activity of combination treatment combining gemcitabine with topotecin against human lung cancer xenografted in nude mice].
Fujita F; Koike M; Fujita M
Gan To Kagaku Ryoho; 2002 Apr; 29(4):577-84. PubMed ID: 11977542
[TBL] [Abstract][Full Text] [Related]
16. Future directions in the chemotherapy of ovarian cancer.
Ozols RF
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-86-S15-90. PubMed ID: 9346230
[TBL] [Abstract][Full Text] [Related]
17. [Intraperitoneal chemotherapy--a method of improving treatment effectiveness in ovarian cancer].
Bespalov VG; Vyshinskaya EA; Vasilieva IN; Maidin MA; Semenov AL; Stukov AN; Kireeva GS; Belyaeva OA; Kopteva OS; Krasilnikova LA; Alexandrov VA; Belyaev AM
Vopr Onkol; 2015; 61(4):634-41. PubMed ID: 26571836
[TBL] [Abstract][Full Text] [Related]
18. Intralesionally implanted cisplatin plus systemic carmustine for the treatment of brain tumor in rats.
Kong Q; Kleinschmidt-DeMasters BK; Lillehei KO
J Surg Oncol; 1998 Oct; 69(2):76-82. PubMed ID: 9808509
[TBL] [Abstract][Full Text] [Related]
19. Clinical-benefit response in advanced non-small-cell lung cancer: A multicentre prospective randomised phase III study of single agent gemcitabine versus cisplatin-vindesine.
Vansteenkiste JF; Vandebroek JE; Nackaerts KL; Weynants P; Valcke YJ; Verresen DA; Devogelaere RC; Marien SA; Humblet YP; Dams NL;
Ann Oncol; 2001 Sep; 12(9):1221-30. PubMed ID: 11697832
[TBL] [Abstract][Full Text] [Related]
20. Oncolytic adenovirus Ad5/3-delta24 and chemotherapy for treatment of orthotopic ovarian cancer.
Raki M; Särkioja M; Desmond RA; Chen DT; Bützow R; Hemminki A; Kanerva A
Gynecol Oncol; 2008 Jan; 108(1):166-72. PubMed ID: 17950450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
